Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Blackwell Science, LtdOxford, UKEJCCEuropean Journal of Cancer Care0961-5423Blackwell Publishing Ltd, 200312137142Original ArticleHypnotherapy and cognitive-behaviour therapy in cancer careTAYLOR & INGLETON Psychological interventions Hypnotherapy and cognitive-behaviour therapy in cancer care: the patients’ view E. E . TA YL O R, bsc, mmedsci, ukcp, director of integrated health care, East Lancashire Integrated Health Care Centre, Rossendale Hospital, Lancashire & C. IN GLET ON , ba, ma, phd, rgn, rnt, cert ed, senior lecturer in nursing, University of Sheffield, School of Nursing and Midwifery, Sheffield, UK TAYLOR E.E. & INGLETON C. (2003) European Journal of Cancer Care 12, 137–142 Hypnotherapy and cognitive-behaviour therapy in cancer care: the patients’ view Psychological intervention is not widely available for emotionally distressed patients with cancer. The purpose of this study is to investigate and report on the experiences of eight patients who participated in a programme consisting of hypnotherapy and cognitive-behaviour therapy. Following the 12-session intervention, qualitative analysis of interview data demonstrated that patients had acquired the skills to enable them to cope, both with invasive medical procedures and the psychological traumas they faced. The findings also indicated some initial misconceptions about hypnotherapy and the need to provide a therapy setting sensitive to the needs of cancer patients undergoing active medical treatment. Keywords: cancer, hypnotherapy, cognitive-behaviour therapy, qualitative results. INT RO D U C TIO N Psychosocial distress and morbidity are frequently reported following the diagnosis of cancer (Derogatis et al. 1983; Zabora et al. 1997), particularly at diagnosis and during active treatment (Hughes 1982; Watson et al. 1992). Medical procedures have a significant impact on quality of life (QOL), not least the side-effects of chemotherapy (Coates et al. 1983; Smith et al. 1991), and the psychological cost can affect treatment compliance (Watson et al. 1992). Adaptation to a cancer diagnosis and QOL are improved when patients are given appropriate information and involved in treatment decisions to the extent they wish (Fallowfield 1997) and the body of literature on psychosocial interventions is extremely positive (cf. Fawzy et al. 1995). However psychotherapy is not widely available and many distressed cancer patients receive no psychological help at all (Greer 1997). This is largely a result of patients concerns not being appropriately identiCorrespondence address: Elizabeth Taylor, East Lancashire Integrated Health Care Centre, Cribden House, Rossendale Hospital, Rossendale, Lancashire, BB4 6NE, UK (e-mail [email protected]) European Journal of Cancer Care, 2003, 12, 137–142 © 2003 Blackwell Publishing Ltd fied (Booth et al. 1996; Heaven & Maguire 1997) as well as lack of available resources. These factors led one unit in the north of England, East Lancashire Integrated Health Care Centre (ELIHCC) to develop a psychotherapeutic intervention to help patients cope with the diagnosis and treatment of cancer. The intervention combines cognitive-behaviour therapy (CBT) and hypnotherapy in a clinical package to meet individual need and has become known locally as the ‘Hypno-Chemo Programme’. This paper presents findings from an evaluation of the programme from the patients’ perspective. After describing the background literature, the paper explores the experiences of participants based upon data gathered from in-depth qualitative interviews conducted with eight patients. The discussion will then locate some of these issues in the wider literature on communication skills, the therapeutic alliance, cognitive and behavioural interventions and appropriate treatment location. The aim of the study is to provide psychotherapists with patients’ perceptions of the value of a combined cognitive-behavioural therapy/hypnotherapy programme for cancer care, in order to inform service provision and dissemination. TAYLOR & INGLETON Hypnotherapy and cognitive-behaviour therapy in cancer care Background literature Hypnotherapy and related procedures such as relaxation training and guided imagery (GI) have been used to ameliorate the side-effects of chemotherapy, help patients adjust to the disease, counteract pain and anxiety and alter the mechanisms of immunity to hopefully improve prognosis. These interventions have been evaluated in a series of studies including individual and group therapy. Extensive reviews of this literature (Morrow & Dobkin 1988; Fawzy et al. 1995; Genuis 1995) have concluded consistently that hypnotherapy is effective in the above areas with the possible exception of enhancing survival. The randomized controlled trials relating to the latter have produced conflicting results with some limited by methodological flaws (Fox 1995; 1998). Influential in the development of the cognitivebehaviour intervention has been the work of Greer et al. (1992) who randomly allocated 174 psychologically distressed, early stage cancer patients to an 8-week CBT programme specifically designed for cancer care or to a no treatment control. The intervention included identification of concerns, cognitive restructuring, behavioural assignments, progressive muscle relaxation and role play/ imagination to deal with imminent stressful procedures. Significant advantages were found for the therapy group on validated psychosocial measures immediately after the intervention and at 4-month follow-up. At 12-month follow-up, patients who had received therapy still had less anxiety and depression than controls (Moorey et al. 1994). There is substantial evidence to demonstrate the efficacy of psychosocial interventions (cf. Fawzy et al. 1995). However, studies reported from the quantitative perspective restrict understanding of the individual patient’s interpretation of events, thus limiting the opportunity to refine interventions more specifically to meet their needs. The results of randomized controlled trials are infrequently implemented in clinical practice (Haines & Jones 1994) and yield results that do not differentiate between patients who most need help and those who would have done well without it (Watson 1983). The hypno-chemo programme The hypno-chemo programme, influenced by the work of Greer et al. (1992) provides adjuvant CBT and hypnotherapy in a structured 12-session programme. Requirements for inclusion are diagnosis of cancer at any stage and a reasonable command of English. Patients with organic brain disease or psychotic illness are excluded. A medical and psychosocial history is ascertained, the intervention 138 explained and treatment plan agreed before written consent is obtained. Hypnosis is induced by eye fixation, passive muscle relaxation and deepening procedures. Treatment typically involves relaxation, confidence building and GI. Patients are taken verbally through the sequence of events leading to, during and following chemotherapy infusions. Occurring anxiety, nausea or other unpleasant sensations are cue controlled by hypnotic suggestion. For example, the patient is asked to visualize a numerical dial representing nausea and practise turning the dial up and down to obtain control. The latter is subsequently associated with a cue word, which is used to reduce nausea in the chemotherapy environment and with associated stimuli. Patients are asked to visualize their white blood cells attacking and destroying cancer cells using images/scenes of their choice. Pain management is included if required. Hypnotic procedures are supported by audiotaped instructions. These methods broadly conform to approaches described by Spiegal & Spiegal 1978; Levitan 1987 and Redd et al. 1983). Cognitive-behaviour therapy is used to identify and resolve cancer-related psychological problems and follows the procedures described by Greer (1997). Participants are encouraged to disclose and express the emotional impact of cancer on themselves and significant others, taught to identify and challenge the automatic dysfunctional thoughts underlying anxiety and depression and replace them with more rational responses. Task focused behavioural assignments are encouraged to generate achievement and raise self-esteem. An attitude of reasonable optimism, determination not to give in, desire to understand/participate in treatment and continue to live a normal life is encouraged. PAT I ENT S AND MET HODS The study was conducted at ELIHCC, which is adjacent to a hospice in northern England. The centre provides complementary therapies and orthodox psychotherapy to three local hospices and community patients and is funded by a grant from the National Lottery Charities Board. Eight patients who had completed the hypno-chemo programme were purposefully selected (Coyne 1997) for inclusion in the study, all white females, aged between 32 and 60 years (average age 49). All presented with a first diagnosis of carcinoma, seven breast and one colon at the stage of local disease or local disease and regional spread. All patients underwent surgery and chemotherapy and seven received radiotherapy. Six patients commenced psychotherapy/hypnotherapy just before or after their first session of chemotherapy. One patient joined the pro- © 2003 Blackwell Publishing Ltd, European Journal of Cancer Care, 12, 137–142 European Journal of Cancer Care Table 1. Interview schedule 1. Can you tell me how you felt when the hypno-chemo programme was offered to you? 2. How do you feel about the therapy now? 3. If you were to go through the programme again or recommend it to someone else with cancer, could you suggest any improvements or changes you would like to make? 4. Is there anything else about the therapy you would like to discuss? gramme approximately halfway through chemotherapy and another after the latter was completed. Semi-structured interviews were conducted between 1 and 24 months (average 7 months) after the intervention. Development of the interview schedule followed a procedure described by Bottomley (1998). This approach prepares the interviewer for topics likely to be raised by participants. Lofland (1971) refers to these topics of interest as ‘puzzlements’, which were jotted down and read by an independent health professional. This allowed a more rigorous spread of the range of enquiry, enabling the researcher to elicit what was ‘puzzling’ in the social context. Each puzzlement/question was written down on a separate piece of paper and sorted into topically related piles. Table 1 outlines the four main areas addressed within the literature. The tape-recorded interviews were conducted by the first author in the patients’ homes, typically taking between 30 min and one hour to complete. The interviews were fully transcribed verbatim for thematic analysis, which requires that the raw data is reorganized under a series of headings reflecting emerging themes. Accordingly a 14-stage model described by Burnard (1991), involving familiarization of the range and diversity of the data, development of a thematic framework, judging the meaning and significance of the data and applying it to the framework and finally categorization was used. FIN D IN G S The primary themes identified from the data were: gaining help, treatment tailored to individual need, long-term benefits and service satisfaction/patient information needs. Gaining help Despite the widely publicised need for psychosocial support at all stages of cancer care and local publicity about the services offered at ELIHCC, some patients had difficulties in accessing the hypno-chemo programme. This is highlighted by the following quote: I was halfway through my chemo before I heard about it, nobody mentioned it before you know . . . If I hadn’t been so poorly, I doubt that she would have mentioned it . . . Referral difficulties may be due to misconceptions about hypnosis and the low priority given to psychosocial concerns. There is substantial evidence to suggest that health professionals are poor at eliciting the latter which is cause for concern in the light of evidence that patients with unresolved problems are at risk of later anxiety and depression (Kornblith et al. 1992; Thomas et al. 1997). Fear of chemotherapy was paramount in the present study and this, coupled with feeling overwhelmed by their diagnosis, led some patients to grasp the hypno-chemo programme as a lifeline. The following extract encapsulates the views of many of the participants: It was actually through my breast care nurse, ahmm – I was doing very badly on my first chemo¢ so I rang her out of desperation to see if she could put me in touch with the Centre. All the research participants received hypnotherapy, though many had negative preconceived beliefs. For example: I could only picture the non-clinical hypnosis; the stage stuff and I didn’t really know what it was. Despite detailed explanation of what to expect in a hypnotic induction, patients assumed they would ‘go under’, meaning lose consciousness or relinquish control to the therapist. These misconceptions may prevent patients who could potentially benefit from hypnotherapy, from seeking reassurance about their concerns and subsequently not obtaining help. Misunderstandings about hospice were also apparent. Some patients were inhibited from attending the Centre because it was next door to a hospice, with patients recommending a separate building off site. Treatment tailored to individual need This theme represents the identification of patients’ main concerns and adopting appropriate therapies to aid their resolution. That is, following the patient’s agenda rather than the therapist’s. For example: They obviously try to assess exactly what your personal needs are and try to work to them. Not only was this appreciated but patients also valued the therapists themselves. Given that the latter is recognized as an important variable in treatment outcome, it © 2003 Blackwell Publishing Ltd, European Journal of Cancer Care, 12, 137–142 139 TAYLOR & INGLETON Hypnotherapy and cognitive-behaviour therapy in cancer care was noteworthy to discover that all patients considered the therapists as skilful and important in their adaptation to the cancer situation, exemplified by the following: a lot more confident probably than I was before, a lot more daring than I used to be and I’ll say what I think to whom I think. I couldn’t have managed without her . . . that was the biggest part of it . . . actually being able to talk . . . These findings support a substantial body of evidence demonstrating the efficacy of behavioural approaches in cancer care (Fawzy et al. 1995; Walker et al. 1999). Understanding the cognitive model and utilizing the techniques within it are considered essential to the efficacy of CBT. However, rather than demonstrating comprehension of the model and separating out the cognitive and behavioural elements, patients tended to view the intervention as a treatment package. A typical vignette illustrates how participants amalgamated CBT aspects with hypnotherapeutic techniques and GI in their understanding of altered thoughts and increased control: I thought I was going to be as sick as anything for 6 months . . . that’s why I was so upset in the beginning because I felt that I’d no control over what was happening . . . I wasn’t a relaxed person before it all started, I was sort of a very busy person and found it hard to switch off and I think it was good . . . it gave me those techniques . . . the fact that I was given a tool whereby I could switch off the nausea . . . The exception to this was relaxation. Patients were very clear on how relaxation helped them, particularly with sleep disturbance and chemotherapy. I had real problems sleeping all the way through my treatment . . . and E gave me a sleep tape . . . which really, really helped, erm – and the relaxation helped. I took it down to my chemotherapy sessions and for the couple of days afterwards when I felt particularly bad, erm – I used to play the tape a few times a day and they really, really did help. Feeling in control, confidence building and the visualization of host defences destroying cancer cells complete this theme and are closely interwoven. The need for control over what was happening to patients was an important finding with the ‘cancer cell attack’ considered a principle tool: I think it really helped me relax all the way through and visualizing that I was actually helping my body to get rid of the cancer and make myself better. The combination of techniques was considered to reduce helplessness and subsequent anxiety, leading to an increase in confidence: I definitely lost confidence in myself. I think in the beginning . . . but I feel as though [laughs] I’ve become 140 Long-term benefits The main purpose of the hypno-chemo programme is to deal with cancer-related distress during active treatment. However it became apparent in the early stages of data collection that patients had continued to benefit from the techniques learned and still used their hypnotherapy tapes. One patient, interviewed 8-months after completion of chemotherapy said: I’m still using the techniques I was taught . . . I had my kitchen replaced . . . and I got thoroughly stressed out . . . I thought you’re going to give yourself cancer back again because you’re just worrying so much so I listened to the cancer cell attack . . . and it was a great help because I got the kitchen . . . done all without having to feel totally stressed out. Service satisfaction and patient information needs This theme focuses on service satisfaction and identifies deficits in information provision. Patients invariably viewed their therapy positively. For example: It was excellent, I can’t fault it. The main critisicm was lack of information about the existence of the service in appropriate clinics, closely followed by the need for health professionals to explain the programme beforehand. The following extract illustrates this: I think that maybe the GPs need . . . more awareness about the availability of this kind of service because they’re the person who has contact . . . and I think it’s very important for them to offer this kind of facility and alternative to the conventional chemical medicines, erm – because I think if it’s worked in conjunction with that, erm – it can only be . . . helpful to the patient. Future availability was a major finding with most patients suggesting follow-up sessions or later treatment on request. There was however, evidence of service dissatisfaction related to medical procedures. Despite the widely publi- © 2003 Blackwell Publishing Ltd, European Journal of Cancer Care, 12, 137–142 European Journal of Cancer Care cised move from closed to open awareness, communication deficits were apparent. For example: . . . and they sent me down for a scan and they found my cancer, but they didn’t mention cancer . . . They just said . . . we’ll have to operate on your bowels . . . and somebody just . . . threw me a paper in at the door and . . . she said, er – that’s to do with your bag [colostomy]. Well . . . it never registered . . . and I have to have a bag? . . . and she left me. I must be honest, I was terrified then. Some patients complained about hospital waiting times, mechanical failure and human error. Oh the, the waiting there was a nightmare . . . They’d say, oh, there’s been a fault in the machine or I’m sorry your prescription should have been ordered last week and it hasn’t and . . . you were trapped there, you couldn’t go home because you’d not had your chemo, you know, you’d wait for your bloods, you’d wait for the doctor, then you’d wait for your treatment. Collectively, the findings highlight the need for open communication, identification of concerns and interventions tailored to individual need. DI SC U SSIO N A ND CONCL US I ONS The findings suggest that the combination of therapies may provide advanced skills in coping/adapting to the cancer situation. Patients were able to describe how having the opportunity to talk about their feelings had helped them and how much they appreciated the therapists. There is substantial evidence to suggest that intervention outcome is determined by the therapeutic relationship (Beck et al. 1987; Ellis 1994) and this study highlights the importance of rapport, and comprehension of the problems facing cancer patients (cf. Faulkner & Maguire 1994). It has been argued (Bottomley 1998) that understanding the cognitive model is essential for patients to benefit from the techniques within it. However, in this study patients clearly expressed the value of CBT, that is their ability to think and/or behave more adaptively, increase confidence and reduce distress without necessarily isolating the underlying principles. Conversely, patients were able to explain in detail how hypnotherapy had helped them relax, sleep and cope more effectively. They were also clear about the ways in which GI had assisted their resolution of chemotherapy related fear and side-effects. Guided imagery was highly valued in helping patients to feel more in control of their situation with all patients keen to visualize their host defences destroying malignant cells. This approach, consistent with published research (Fawzy et al. 1995; Walker et al. 1999), is never portrayed as a cure for cancer but as a tool to encourage patients to take an active role in their rehabilitation. One important finding was that some patients experienced difficulties with referral, which may reflect communication deficits (Heaven & Maguire 1997) and/or mistrust of hypnotherapy. The latter supports former anecdotal reports of perceived witchcraft and involuntary mind control (Redd & Hendler 1984). Such notions, perpetuated by the popular press (Hendler & Redd 1986) and abuse by stage hypnotists (Finlay & Jones 1996) have led to fearful and sceptical views. Despite their original concerns however, patients in this study were able to describe in some detail how hypnotherapy had helped them, suggesting this may be a valuable intervention. Another relevant finding was that some patients objected to ELIHCC being adjacent to a hospice. Walker et al. (1999) have demonstrated the benefits of a setting sensitive to the needs of patients undergoing chemotherapy and it would appear that hospice-based community care might be less sensitive to patient need in the active stages of treatment than a hospital-based centre. Conversely, the analysis illustrated some dissatisfaction with hospital-based procedures, in particular, inappropriate communication, long waiting periods, technical breakdown and staff oversight. These findings mirror those of previous research highlighting the superiority of hospice care to that of hospital care, especially for psychosocial issues (cf. Wilkinson 1999). The evidence therefore suggests that a hospital-based cancer unit described by Walker et al. (1999) or a stand-alone centre would be less inhibitory and more suited to the needs of this particular client group. The latter were keen to recommend the service but were concerned about the lack of availability. CONCLUSI ON The study supports the body of literature demonstrating the value of psychosocial interventions in cancer care while adding further insights to the patient experience that is not always possible using more structured quantitative methods of enquiry. The findings from this study will be used to refine provision in terms of providing a more appropriate setting and easier access, as well as integrating the findings into teaching sessions. Further recommendations include an outcome study to assess the efficacy of the combined intervention. © 2003 Blackwell Publishing Ltd, European Journal of Cancer Care, 12, 137–142 141 TAYLOR & INGLETON Hypnotherapy and cognitive-behaviour therapy in cancer care ACKN O W L E D G E M E NT S The study was sponsored by the National Lottery Charities Board. Approval for the study was granted from the local Research Ethics Committee, Rossendale, Lancashire. We are grateful to Helen Hills, East Lancashire Integrated Heath Care Centre, for data accuracy checking and Dr Bill Noble, Trent Palliative Care Centre, for supervision. REFE RE N C E S Beck A.T., Shaw A.J. & Rush B.F. (1987) Cognitive Therapy of Depression. Wiley and Sons, New York. Booth K., Maguire P.M. & Butterworth T. (1996) Perceived professional support and the use of blocking behaviour by hospice nurses. Journal of Advanced Nursing 24, 522–527. Bottomley A. (1998) Group cognitive behavioural therapy with cancer patients: the views of women participants on a shortterm intervention. European Journal of Cancer Care 7, 23–30. Burnard P. (1991) A method of analysing interview transcripts in qualitative research. Nurse Education Today 11, 461–466. Coates A., Abraham S., Kaye S.B. et al. (1983) On the receiving end: patient perception of the side-effects of cancer chemotherapy. European Journal of Cancer 19, 203–208. Coyne I. (1997) Sampling in qualitative research, purposeful and theoretical sampling; merging or clear boundaries? Journal of Advanced Nursing, 26, 623–630. Derogatis L.R., Morrow G.R. & Fetting J. (1983) The prevalence of psychiatric disorders among cancer patients. Journal of the American Medical Association 249, 751–757. Ellis A. (1994) Reason and Emotion in Psychotherapy. Carol Publishing Group, New York. Fallowfield L.J. (1997) Offering choice of surgical treatment to women with breast cancer. Patient Education and Counselling 30, 209–214. Faulkner A. & Maguire P. (1994) Talking to Cancer Patients and Their Relatives. Oxford University Press, Oxford. Fawzy F.I., Fawzy N.W., Arndt L.A. & Pasnau R. (1995) Critical review of psychosocial interventions in cancer care. Archives of General Psychiatry 52, 100–113. Finlay I.G. & Jones O.L. (1996) Hypnotherapy in palliative care. Journal of the Royal Society of Medicine 89, 493–496. Fox B.H. (1995) Some problems and some solutions in research on psychotherapeutic interventions in cancer. Supportive Care Cancer 3, 257–263. Fox B.H. (1998) A hypothesis about Spiegel et al.’ s 1989 paper on psychosocial intervention and breast cancer survival. Psycho-Oncology 7, 361–370. Genuis M.L. (1995) The use of hypnosis in helping cancer patients control anxiety, pain and emesis: a review of recent empirical studies. American Journal of Clinical Hypnosis 37, 316–323. Greer S. (1997) Adjunctive psychological therapy for cancer patients. Palliative Medicine 11, 240–244. Greer S., Moorey S., Baruch D.R. et al. (1992) Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. British Medical Journal 304, 675–680. 142 Haines A. & Jones R. (1994) Implementing findings of research. British Journal of Medicine 308, 1488–1492. Heaven C.M. & Maguire P. (1997) Disclosure of concerns by hospice patients and their identification by nurses. Palliative Medicine 11, 283–290. Hendler C.S. & Redd W.H. (1986) Fear of hypnosis: the role of labelling in patients’ acceptance of behavioural interventions. Behaviour Therapy 17, 2–13. Hughes J. (1982) Emotional reactions to the diagnosis and treatment of early breast cancer. Journal of Psychosomatic Research 26, 277–283. Kornblith A.B., Anderson J., Cella D.F.et al. (1992) Hodgkin’s disease survivors at increased risk for problems in psychosocial adaptation. Cancer 70, 2214–2224. Levitan A.A. (1987) Hypnosis and oncology. In: Wester, Clinical Hypnosis: a Case Management Approach. pp. 332–356. Behavioural Science Centre, Cincinnati: Lofland J. (1971) Analysing Social Settings, Wandsworth, Belmont, CA. Moorey S., Greer S., Watson M. et al. (1994) Adjuvant psychological therapy for patients with cancer: outcome at one year. Psycho-Oncology 3, 39–46. Morrow D.R. & Dobkin P.L. (1988) Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, aetiology and behavioural interventions. Clinical Psychology Review 8, 517–556. Redd W.H. & Hendler C.S. (1984) Learned aversions to chemotherapy. Health Education Quarterly 10, 57–66. Redd W.H., Rosenberger P.H. & Hendler C.S. (1983) Controlling chemotherapy side effects. American Journal of Clinical Hypnosis 25, 161–172. Smith D.B., Newlands E.S., Rustin G.J.S. et al. (1991) Comparison of ondansetron and ondansetron plus dexamethasome as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338, 487–490. Spiegal H. & Spiegal D. (1978) Trance and Treatment. Basic Books, New York. Thomas S.F., Glynne-Jones R. & Chait J. (1997) Anxiety in longterm cancer survivors influences the acceptability of planned discharge from follow-up. Psycho-Oncology 6, 190–196. Walker L.G., Walker M.B., Ogston K. et al. (1999) Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. British Journal of Cancer 80, 262–268. Watson M. (1983) Psychological intervention with cancer patients: a review. Psychological Medicine 13, 839–846. Watson M., McCaron J. & Law M. (1992) Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens. British Journal of Cancer 66, 862–866. Wilkinson E.J. (1999) Patient and carer satisfaction. In: Providing a Palliative Care Service. (eds, Bosanquet M. Salisbury C.) pp. 97–130, Oxford University Press, Oxford Zabora J.R., Blanchard C.G. & Smith E.D. (1997) Prevalence of psychological distress among cancer patients across the disease continuum. Journal of Psychosocial Oncology 15, 73– 87. © 2003 Blackwell Publishing Ltd, European Journal of Cancer Care, 12, 137–142